Evidence map›Paper›PMID 42604042›Full record

ArticleJHLT open2026

Ventilation heterogeneity early post lung transplant as a marker of future bronchiolitis obliterans syndrome and mortality - A 10 year study.

Bruce R Thompson, Matthew J Ellis, Pam Matsas, Sylvia Verbanck, Greg I Snell

Abstract read
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruce R ThompsonMelbourne School of Health Science, The University of Melbourne, Melbourne, Australia.
Matthew J EllisCentral Clinical School, Monash University, Melbourne, Australia.
Pam MatsasCentral Clinical School, Monash University, Melbourne, Australia.
Sylvia VerbanckRespiratory Division, University Hospital UZ Brussel, Brussels, Belgium.
Greg I SnellCentral Clinical School, Monash University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung transplantation (LTx) is regarded as an effective treatment of end-stage lung disease, yet recipients are at significant risk of developing Bronchiolitis Obliterans Syndrome (BOS). Previous studies have shown that BOS is related to ventilatory heterogeneity, IL-8 and airway hyper-responsiveness (AHR). What has been less explored is the potential for these measures taken early post-LTx to predict future BOS or death. Methods: Double LTx patients had spirometry, and measures of acinar (S Results: Of the 33 patients recruited, 17 patients developed BOS, and 13 died over the follow-up period. The patients who had an S Conclusion: We have demonstrated that increased S

Indexed as

BOSCLADIL-8Lung rejectionVentilation heterogeneity

Identifiers

PMID42604042
PMCPMC13476564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.